# ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma

> **NCT01459484** · PHASE2 · COMPLETED · sponsor: **Italian Sarcoma Group** · enrollment: 225 (actual)

## Conditions studied

- Osteosarcoma

## Interventions

- **DRUG:** Mifamurtide arm
- **OTHER:** 3 drugs arm

## Key facts

- **NCT ID:** NCT01459484
- **Lead sponsor:** Italian Sarcoma Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-23
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01459484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01459484, "ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01459484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*